TET2 frameshift and nonsense mutations were frequently identified in AITL (~70%), PTCL-NOS (~60% in TFH cell marker expressing subtype), and CTCL (~10%) [75,96–98]. The gene discussed is TET2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.